Rapt Therapeutics Inc (NASDAQ:RAPT)
| 29.10 Delayed Data As of 3:59pm ET |  -0.10 / -0.34%Today’s Change | 9.86 Today|||52-Week Range 40.74 | -20.77% Year-to-Date |
Latest RAPT News | Press Releases
| Can Rapt Therapeutics (RAPT) Climb 59% to Reach the Level Wall Street Analysts Expect? 9:55am / Zacks.com - Paid Partner Content | Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates Aug 09 / Zacks.com - Paid Partner Content |
| Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates Aug 11 / Zacks.com - Paid Partner Content | Gritstone bio Inc. (GRTS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.20 |
| Today’s open | 29.14 |
| Day’s range | 28.14 - 30.17 |
| Volume | 20,483 |
| Average volume (3 months) | 340,292 |
| Market cap | $832.3M |
Data as of 3:59pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | -15.29% |
| Earnings growth (this year) | -18.10% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.38% |
| P/E ratio | NM |
| Price/Sales | 263.85 |
| Price/Book | 4.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALTAltimmune Inc | +0.11 | +0.63% |
| AGENAgenus Inc | -0.15 | -4.78% |
| STOKStoke Therapeutics I... | -1.44 | -6.71% |
| MORMorphoSys AG | -0.14 | -2.28% |
Data as of 4:00pm ET, 08/16/2022
Financials
| Next reporting date | December 14, 2022 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $3.8M |
| Annual profit (last year) | -$69.2M |
| Net profit margin | -1,814.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
